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Purpose. To report a case of unilateral optic neuritis following Measles-Mumps-Rubella (MMR) vaccination.Methods. A 30-year-
old female developed unilateral optic neuritis five days after a Measles-Mumps-Rubella (MMR) booster vaccination. The patient
displayed unilateral involvement, with severe visual loss.However, visual acuity improved significantly after four days of intravenous
steroid therapy with 500mg/day of methylprednisolone.Conclusions. Optic neuritis is one of the rare complications associated with
themumps, measles, and rubella vaccine. It may be a toxic reaction to the nonviral component of the vaccine, but the exact etiology
is unknown. Postvaccination neuritis is generally bilateral and usually affects children. In adults, unilateral optic neuritis is usually
correlated with multiple sclerosis (MS).
1. Introduction
Optic neuritis is an inflammatory, infectious, or demyelinat-
ing disorder affecting the optic nerve. Bilateral optic neuritis
usually affects children and often follows viral infections,
while it rarely affects adult patients not suffering from sys-
temic inflammatory or autoimmune disease. In adults, optic
neuritis is typically unilateral and is correlated with multiple
sclerosis (MS) [1].
In rare cases optic neuritis may develop after vaccina-
tion injections. Postvaccination neuritis is generally bilateral
and only rarely unilateral. The medical literature includes
cases of optic neuritis developing after vaccinations for
tuberculosis, hepatitis B, rabies, tetanus, meningitis, anthrax,
mumps, measles, and rubella [1]. The influenza vaccine is
also associated with a higher incidence of optic neuritis [1].
Optic neuritis following MMR vaccination usually develops
between one week and a maximum of one month after
administration of the vaccine [2–6]. However, a case of a
patient who experienced a worsening vision as soon as only
24 hours after vaccination has been recorded [7].
2. Case Presentation
A healthy 30-year-old woman complained of headache and
fever two days after administration of the MMR vaccine.
About five days later, the patient reported a unilateral blurring
of vision. She underwent a full ophthalmologic examination
at the emergency department of the Ophthalmology Clinic
in Trieste General Hospital. Visual acuity was found to be
20/20 in both eyes and the slit-lamp examination showed an
anterior segment without signs of inflammation. Intraocular
pressure was 14mmHg in both eyes. On fundus examination
of the right eye the optic disc appeared to be normal whereas
the left eye optic disc margin was blurred. Fluorescein
Angiography (FA) of the left eye showed the edges of the
optical disc to be blurred, revealing the early stages of
hyperfluorescence.Therewas no other angiographic evidence
of disease in the left eye. Moreover, the right eye was within
the normal angiographic range. Two color photographs of the
fundus were taken confirming the presence of optic nerve
head edema.
On the third day after the first examination visual acuity
was found to be 20/100 BCVA. The patient was treated with
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Figure 1: Visual field. (a) In acute phase. (b) After 5 days from treatment. (c) After 40 days from treatment.
Table 1: Visual Evoked Potentials (VEP) in acute phase.
VEP pattern 60󸀠 VEP pattern 15󸀠
Amplitude (uV) 2.93 2.42
Latency (ms) 109.57 109.57
500mg i.v. of methylprednisolone for four days. The Com-
puterized Perimetry Test (Figure 1(a)) revealed an overall
reduction in the visual field. Electrophysiological exams were
performed: the Visual Evoked Potentials (VEP) showed an
increased latency and a reduction in amplitude (Table 1).
Additional radiological investigations were deemed nec-
essary: a CT head scan, with and without contrast medium,
and magnetic resonance imaging (MRI) of the brain, with
and without contrast medium. Following administration of
the contrast medium, the CT scan disclosed a nonhemor-
rhagic ultradense lesion with no signs of focal encephalitis
injuries. The MRI revealed minor thickening of the left optic
nerve, corresponding to an increased intensity of the T2
signal within a framework involving hyperemia and edema.
Four days of infusion therapy was followed by ten days
of oral corticosteroid therapy, with a gradually diminishing
dosage. Visual acuity remained stable at 20/100 BCVA for the
next five days and was followed by a gradual improvement in
visual acuity.The Computerized Perimetry Test was repeated
(Figure 1(b)) and showed a significant improvement. A
scotoma remained in a peripheral superonasal position in
the left eye. After forty days, visual acuity was found to
be 20/20 BCVA and the visual field was within normal
limits (Figure 1(c)). Electrophysiological exams revealed an
improvement, with a lower VEP latency and an increased
amplitude (Table 2).
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Table 2: Visual Evoked Potentials (VEP) after 40 days from
treatment.
VEP pattern 60󸀠 VEP pattern 15󸀠
Amplitude (uV) 6.92 5.09
Latency (ms) 97.85 114.84
3. Discussion
The Measles-Mumps-Rubella vaccine consists of MMR and
live attenuated virus prepared in baby chick embryo cell
cultures.
Adverse events associated with theMMR vaccination can
vary from simple local pain to rare systemic disorders, such
as anaphylactic shock. Over the last thirty years, six cases of
optic neuritis following vaccination against measles, mumps,
and rubella have been reported.
Kazarian and Gager [2] reported the case of a 6-year-
old boy who developed bilateral optic neuritis only 18 days
after administration of the trivalent vaccine. Kline et al.
[3] described a case of a 31-year-old woman who devel-
oped bilateral optic neuritis 11 days after a vaccination for
rubella. Riikonen [4] diagnosed a unilateral optic neuritis
and subsequent multiple sclerosis four weeks after rubella
vaccination. Stevenson et al. [5] reported two cases, both
involving 13-year-olds who developed optic neuritis 2-3
weeks after vaccination for measles and rubella, Arshi et al.
[7] described a case of rapid onset optic neuritis in which
the complication came out just in few hours in a 16-year-old
boy, and Moradian and Ahmadieh [6] reported two cases of
optic neuritis with onset less than 24 hours followingmeasles-
rubella vaccination.
To the best of our knowledge, there are no papers in
the literature describing a case of unilateral optic neuritis
following MMR vaccination in an adult without known sys-
temic inflammatory or autoimmune disorders. Our patient
developed optic neuritis about five days after being given
a dose of MMR vaccine. As in the cases described in the
literature above, neurological complications occurred within
a week to one month of the administration of the MMR
vaccine, long enough to increase the antibody titer and
antigen-antibody complexes. Damage was due to immune
complex disease, which caused vascular lesions and led to
hyperemia and perivascular inflammation, with consequent
rupture of the blood-brain barrier [4, 5]. An etiopathogenetic
mechanism is consistent with the foregoing condition.
Optic neuritis is one of the rare complications associated
with the mumps, measles, and rubella vaccine. This neu-
rological disorder may be a toxic reaction to the nonviral
component of the vaccine [4] and is probably caused by
the antibody titer against live attenuated virus. It should be
stressed that this is a temporary clinical situation, which
resolves after administration of a high dose of corticosteroid
in the initial phase of the therapy. However, it can lead to both
unilateral and bilateral optic neuritis and can affect both sexes
and all ages in subjects who undergo vaccination.
Another purpose of this case report is to underline
the importance of assessing a patient’s medical history and
establishing the correlation between clinical symptoms and
the MMR vaccine, not least because vaccination campaigns
are recognized and supported by the WHO (World Health
Organization) throughout the world.
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